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442A Practical Guide to Multimodality Imaging of Transcatheter Aortic
Valve Replacement
The advent of transcatheter aortic valve replacement (TAVR) is one of the most widely anticipated advances in the care of
patients with severe aortic stenosis. This procedure is unique in many ways, one of which is the need for a multimodality
imaging team-based approach throughout the continuum of the care of TAVR patients. Pre-procedural planning, intra-
procedural implantationoptimization, and long-term follow-upof patients undergoing TAVR require the expert use of various
imaging modalities, each of which has its own strengths and limitations. Divided into 3 sections (pre-procedural, intraproce-
dural, and long-term follow-up), this review offers a single source for expert opinion and evidence-based guidance on how to
incorporate thevariousmodalities at each step in thecareof aTAVRpatient. Althoughmuchhasbeen learned in the short span
of time since TAVRwas introduced, recommendations are offered for clinically relevant research thatwill lead to refinement of
best practice strategies for incorporating multimodality imaging into TAVR patient care. (J Am Coll Cardiol Img 2012;5:
441–55) © 2012 by the American College of Cardiology Foundationt
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pPercutaneous placement of aortic valve prostheses is
among the most widely anticipated innovations of
the past decade (1,2). Such success is critically
dependent on careful patient selection, optimal
performance of a complex and technically demand-
ing implantation procedure, and careful postopera-
tive care. Multimodality imaging has emerged as an
important ingredient of each of these steps such
that the care team for patients undergoing percuta-
neous transcatheter aortic valve replacement
(TAVR) must include skilled and knowledgeable
cardiologists and radiologists able to perform and
interpret a variety of imaging techniques, often in
real time during the implantation procedure and
who have specific expertise in TAVR imaging. The
goal of this review is to comprehensively demon-
strate how physicians currently derive multimodal-
ity imaging information and integrate it into the
decision-making process for patient care for both
self-expanding and balloon expandable TAVR.
This review offers guidance for future imagers
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MAB for Edwards Lifesciences and GE Healthcare. All other authors
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this paper to disclose.Manuscript received September 27, 2011; revised manuscript received
November 27, 2011, accepted December 13, 2011.involved in this novel procedure and provides the
basis for standardization of the imaging approach to
TAVR, which has been lacking. In 3 sections
(pre-procedural, intraprocedural, and long-term
follow-up assessments), we highlight the impor-
tance of multimodality imaging and, when appro-
priate, compare the utility of various modalities. In
some instances, local expertise will dictate which
modalities are employed at each stage. It is hoped
that this practical review addresses the requirements
for and utility of multimodality imaging in the
continuum of TAVR patient care.
Pre-procedural Assessment
Multimodality imaging goals. The overall goals of
he pre-procedural assessment are to: 1) ensure
atient suitability for the proposed access site;
) ensure that the proposed device can be safely and
uccessfully implanted on the basis of device char-
cteristics and the anatomic relationships between
he aortic valve and root, left ventricle (LV), and
oronary ostia; 3) select the device size; and
) contribute to the development of a procedural
lan.
Determining eligibility for iliofemoral vascular access.
CONVENTIONAL ANGIOGRAPHY. Vascular access
complications are common in TAVR implantation,
with recently published rates ranging from 6.3% to
30.7% (1,3–5). These rates are influenced by various
clinical factors, screening protocols, and the diam-
eter of the arterial sheaths used. Given this high
burden of vascular injury, increasing the effective-
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443ness of pre-procedural screening of patients for
TAVR is key. This often begins with conventional
angiography, because virtually all patients undergo
assessment of the descending aorta, abdominal
aorta, and iliofemoral system to detect stenosis,
occlusion, and aneurysmal disease of the proposed
access site. Angiography provides a basic assessment
of luminal size but a very limited evaluation of the
presence of atherosclerosis and plaque burden as
well as the degree of vessel tortuosity.
MULTIDETECTOR COMPUTED TOMOGRAPHY. Be-
cause of the limitations of angiography, multidetec-
tor computed tomography (MDCT) has become
the single most important imaging modality for
examination of the abdominal and iliofemoral ar-
teries. A standardized approach reduces morbidity
and mortality rates from vascular injury (6) and
includes a number of reconstructions, including
3-dimensional (3D) volume rendered imaging,
curved multiplanar reformats, and maximum inten-
sity projection images (Fig. 1). Employing a cen-
terline approach to elongate the vessel image, mul-
tiple luminal measurements should be made in a
plane orthogonal to the vessel rather than in the
transverse axial plane. With this approach, MDCT
can evaluate vessel size, degree of calcification,
minimal luminal diameter, plaque burden, and ves-
sel tortuosity and also identify high-risk features
including dissections and complex atheroma. An-
gulations in the iliofemoral system 90° might
preclude insertion of large-bore catheters or cause
significant vessel trauma. In the absence of severe
calcification, bulky atheromatous burden, or severe
tortuosity, short segments of relatively compliant
artery can be up to 1- to 2-mm smaller in diameter
Figure 1. Multi-Detector Computed Tomography Visualization o
(A) Three-dimensional volume rendered image of the iliofemoral ve
play the site of minimal luminal diameter. (B) Curved multiplanar re
severe aortic stenosis. The curved multiplanar reformat demonstrat
nal diameter and degree of encroachment by calciﬁed plaque in multipthan the intended sheath, allowing it to be
safely cannulated (7). Less than 180° of
calcification and eccentric calcification are
less likely to create procedural difficulty
than almost circumferential and luminal
calcification. A sheath/femoral artery ratio
of 1.05 or higher has also been shown to
predict both vascular complications and
30-day mortality (8). Although minimal
vessel diameters have been suggested (7),
as smaller sheaths become available the
optimal vessel diameter is likely to be a
moving target. In general, when imaging
characteristics are unfavorable, alternative
approaches such as transapical, transaxillary,
or direct aortic should be considered
(7,9). It should be emphasized that, as
devices and technology change, the im-
aging parameters used to assess patient
suitability and access planning might be
modified (6). To help reduce the risk of
contrast-induced nephropathy, protocols
have been published that employ direct
power injection of diluted contrast in the
infra-renal aorta and provide excellent
image quality (6,10).
ULTRASOUND. Surface ultrasound of the access site
s not frequently used but can be helpful to assess
essel size, tortuosity, and calcification and identify
he optimal site for puncture (11). Intravascular
ltrasound is helpful to see the lumen in patients
hen there is blooming artifact from calcifications.
oronary intravascular ultrasound catheters can be
sed in the periphery at time of diagnostic coronary
ngiography for this purpose.
ofemoral Vasculature
s and boney pelvis. This reconstruction provides landmarks to dis-
at of the right iliofemoral system in an 84-year-old male with
longation of the arterial system and allows for assessment of lumi-
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444Aortic root assessment for TAVR: device sizing and
selection. Imaging of the aortic root and heart for
pre-procedural device sizing and selection and proce-
dural planning and execution is performed with the
goals of: 1) measuring aortic annulus size; 2) measur-
ing leaflet length and calcification; 3) locating the
coronary ostia; 4) identifying other features that might
interfere with successful implantation; and 5) contrib-
uting to pre-procedural planning. In particular, a
careful multimodality imaging evaluation with
MDCT, echocardiography, and root angiography will
identify high-risk predictors of complications in ad-
vance and might result in patient exclusion or other
anticipatory action.
Aortic Root Anatomy
m of aortic root anatomy showing coronet shape and location of
nular planes and coronary ostia relative to leaﬂet attachments. (B)
lanes and leaﬂet attachments from (A) shown superimposed on
m specimen. Reprinted, with permission, from Piazza et al. (12).
to-mitral; VA  ventriculo-arterial.
Table 1. Device Dimensions and Recommended Echocardiograp
THV Height THV Skirt Covera
SAPIEN 23 mm 14.5 mm 7.74–10.1 mm
SAPIEN 26 mm 16mm 8.67–11.4 mm
CoreValve 26 mm 53mm 12mm
CoreValve 29 mm 59mm 12mm
Device dimensions and recommended echocardiographic aortic root measureme
(Medtronic, Minneapolis, Minnesota) transcatheter heart valves (THVs) (from PiazzaAortic valve and root anatomy and transcatheter heart
valve characteristics. To fully understand the use
nd value of imaging it is essential to appreciate the
omplex anatomy of the aortic valve and root and
he specifications of transcatheter heart valves
THVs) currently available. The aortic annulus, the
ommissures, the sinuses of Valsalva, the coronary
stia, and the sinotubular junction (STJ) are the
ramework in which the valve leaflets are suspended
12) (Fig. 2). It is well-established that the annulus
s an oval-shaped, 3-pronged coronet with 3 anchor
oints at the nadir of each aortic cusp rather than a
ylindrical structure. The attachment of the aortic
usps is semilunar, extending throughout the aortic
oot from the LV distally to the STJ. Two virtual
ings are usually defined: an inferior basal ring
ormed by joining the basal attachment of the
eaflets (aortic annulus), and a superior ring at the
op of the crown that is a true ring, corresponding
o the STJ (12) (Fig. 2). The aortic annulus mea-
urement by all modalities is assessed at the lowest
inge point of the aortic valve leaflets at the virtual
asal plane in systole.
The THV characteristics are also important and
ust be integrated with imaging findings (Table 1).
he height of the valve prosthesis and the parts of
he prosthesis that are covered by fabric (the “skirt”)
re important to understand with regard to pre-
rocedural planning and implantation. In the SAPIEN
Edwards Lifesciences, Irvine, California) valve, the
kirt covers the proximal 2 links, whereas in the
oreValve (Medtronic, Minneapolis, Minnesota)
he proximal 12 mm are covered, and the valve
eaflets are mounted supra-annularly. This is an
mportant distinction, because high placement
ight interfere with coronary flow and future access
s well as increase the likelihood of significant
aravalvular regurgitation.
Aortic annulus measurement. Accurate aortic annu-
us measurement is critical for the success of the
AVR, because the size of the annulus will deter-
ine the size of the prosthesis that should be used
Aortic Root Measurements
Recommended Aortic
Annulus Size
Recommended Annulus
to Ostia Height
18–21 mm 10 mm
22–24.5 mm 11 mm
20–23 mm n/a
23–27 mm n/a
for the use of the SAPIEN (Edwards Lifesciences, Irvine, California) and CoreValveFigure 2.
(A) Diagra
various an
Imaging p
postmortehic
ge
nts
et al. [12] and Jayasuriya et al. [13]).
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445(12,13) (Table 1). Mismeasurement of the annulus
is the most common reason for complications such
as aortic regurgitation (AR) (14). Systolic annulus
measurement can be obtained by virtually any tech-
nique, although results differ across modalities in
magnitude and reproducibility, including the ability
to accurately capture the true elliptical anatomy of
the annulus (Online Figs. 1 and 2).
ECHOCARDIOGRAPHY. Echocardiographic mea-
urements of the aortic annulus for selecting THV
ize (Table 1) have traditionally used the sagittal
lane acquired from a 2-dimensional (2D) paraster-
al long-axis image on transthoracic echocardiog-
aphy (TTE) or a mid-esophageal long-axis trans-
sophageal echocardiography (TEE) image between
20° and 140° (Fig. 3). The annular dimension most
ommonly used in decision-making for TAVR bisects
he annulus at its maximum diameter during early-
ystole, from the hinge point of the right coronary
usp to the left-noncoronary commissure. When
he cusps are open in systole, the commissure
easurement is particularly difficult, and care must
e taken not to measure too far into the aortic root.
ransesophageal echocardiography measurements
nderestimate cylindrical sizers during surgery (15),
ecause of the oval shape of the annulus. Biplane
maging or 3D reconstruction can be used to obtain
easurements in the sagittal and coronal planes.
inally, TEE imaging of balloon aortic valvulo-
lasty might help define the annular dimension in
ifficult cases.
MDCT. Recent improvements in MDCT spatial and
emporal resolution and higher detector number
ystems allow imaging of the aortic root with a
inimal slice thickness of 0.5 to 0.75 mm, resulting
n almost isotropic datasets allowing oblique recon-
Figure 4. Measurement of the Aortic Annulus With Multi-Detect
(A) Coronal plane view through the long axis of the left ventricular
by the red arrow. (B) Sagittal plane view through the long axis of t
is depicted by the yellow arrow. Transverse plane reconstructed with ttruction without degradation of spatial resolution.
he aortic annulus plane is obtained by a double
blique multiplanar reconstruction with 2 orthogo-
al planes representing the short and long axis of
he virtual basal ring (Fig. 4). Measurements are
aken from systolic phase reconstructions ranging
rom 20% to 45% of the R-R interval, during
Figure 3. Biplane Echocardiographic Imaging Identiﬁes the
Sagittal Imaging Plane That Bisects the Largest Dimension of th
Aortic Annulus
(A and B) Biplane transthoracic imaging shows the sagittal (A) and
responding transverse (B) plane. The yellow arrows deﬁne the ima
plane for the orthogonal view. The red arrow shows the appropria
annular measurement in the on-axis sagittal plane. (C and D) Biplan
transesophageal imaging shows the sagittal (C) and corresponding
transverse (D) plane. Red arrow in panel C shows the appropriate
annular measurement in the on-axis sagittal plane.
omputed Tomography
ﬂow tract. The longer dimension of the aortic annulus is depicted
eft ventricular outﬂow tract. The shorter dimension of the annuluse
cor-
ging
te
eor C
out
he lhe double oblique technique of multiplanar reconstruction (C).
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446retrospective electrocardiographic gating imaging,
using the phase with the maximum valve opening as
is performed in echocardiography. Computed to-
mography (CT)-based sizing guidelines under de-
velopment integrate 3D data afforded by CT into
the prosthesis selection process, with recommenda-
tions as follows for MDCT mean basal ring mea-
surements: 23-mm valve for annulus 19.5 to
22.5 mm, 26-mm valve for 22.5 to 26.5 mm,
nd 29-mm valve for 26.5 to 29.5 mm (16).
CARDIAC MAGNETIC RESONANCE. Cardiac mag-
netic resonance (CMR) allows for an anatomic and
functional assessment of the aortic valve and aortic
root. However, similar to standard echocardiogra-
phy, most CMR sequences are 2D with the plane of
imaging chosen at the time of the examination (17).
Whole heart, echo-gated 3D CMR with contrast
and a slice thickness of 1.5 mm, a spatial resolution
of 1 mm in-plane and 1 mm through plane (com-
pared with 0.5  0.5  0.5 mm by MDCT)
provides isotropic images for multiplanar recon-
struction and shows the oval shape of the annulus
with maximal and minimal diameters (Online Fig. 2).
COMPARISON OF AORTIC ANNULUS MEASUREMENTS
BY TTE, TEE, CMR, AND MDCT. Every technique has its
advantages and disadvantages (Tables 2 and 3), and it
ften falls to the operator and to local expertise to
ake the safest and most cost-effective choice. The
agittal plane measurement of the aortic annulus by
TE and TEE usually approximates the minor axis
f the elliptically shaped annulus as measured by
DCT. The coronal plane is typically the major
Table 2. Relative Usefulness of TEE, CT, and CMR for Aortic
Valve and Root Characteristics
Aortic Root Imaging Modality
TEE CMR
2D 3D CT 2D 3D
AS severity     
Aortic valve
morphology
    
Calcium distribution    — —
Aortic root orientation — —   
Aortic annulus diameter     
Aortic root morphology
(size and shape)
    
Coronary ostia to aortic
annulus distance
    
— not useful; limited usefulness; useful; very useful; 2D
2-dimensional; 3D  3-dimensional; AS  aortic stenosis; CMR  cardiac
magnetic resonance; CT  computed tomography; TEE  transesophageal
echocardiography.larger) dimension and corresponds to the maxi-um dimension measured from the anteroposterior
iew on cine-angiography. In general, the annulus
ize as measured by TTE is 1-mm smaller than
easurements by TEE, and the TEE measurement
s 1.0-mm to 1.5-mm smaller than MDCT mea-
urement (18,19). There are no studies to date
omparing CMR measurements of the annulus
ith those by echocardiography or MDCT. De-
pite these differences, TAVR outcomes with the
onventional anteroposterior (sagittal plane) diam-
ter by TEE are excellent (19), and TTE or TEE
ortic annulus measurement continues to be the
old standard.
Imaging of the aortic leaﬂets and coronary ostia. Echo-
ardiography, CMR, or MDCT can be used to
easure the distance from the annulus/leaflet hinge
oint to the left main ostium and the length of the
orresponding coronary cusp, important parameters
n planning strategies to reduce the risk of coronary
bstruction (9). Multiplanar 3D techniques (i.e.,
EE, MDCT, or CMR) allow for reconstruction
f the plane of the coronary ostia with correspond-
ng better visualization and assessment of these
omplex structures and their interrelationships (Fig. 5).
icuspid aortic valves are considered contraindica-
ions to TAVR, although it can be difficult to assess
hether a valve is bicuspid or not when it is heavily
alcified.
Both echocardiography and MDCT can evaluate
he extent, location, and distribution of aortic annulus
nd leaflet calcifications, thereby providing important
nformation for successful implantation, although se-
ere calcification might cause acoustic shadowing with
chocardiography. For this reason and due to the high
patial resolution of MDCT, this method is currently
he test of choice in quantifying severity and identify-
ng the location of aortic cusp calcification. Because of
he signal void caused by calcium, CMR is not a
uitable choice. Multimodality imaging also provides
aluable information about the distribution and extent
Table 3. Comparative Test Characteristics of TEE, CT,
and CMR for Aortic Root Imaging
Aortic Root Imaging
CMR
TEE CT 2D 3D
Radiation No Yes No No
Contrast No Yes No Yes
Cost Lower Higher Higher Higher
Length of test Longer Very short Longer Longer
Need for sedation Yes No No NoAbbreviations as in Table 2.
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447of calcification in other areas, such as the mitral
annulus. For example, dense calcification in the inter-
trigonal area (the aortomitral curtain) increases the
risk of paravalvular AR due to asymmetric expansion
of the stented valve (20).
Concomitant cardiac pathology. The degree of LV
ypertrophy, particularly upper septal hypertrophy
nd the angle between the aorta and the LV are
mportant in planning the TAVR procedure. A
eptal bulge protruding into the left ventricular
utflow tract (LVOT) provides a challenge to the
perator in the accurate placement of the valve and
resents a significant risk of THV repositioning
ith cessation of the pacing run. Left ventricular
ysfunction also influences the strategy of the pro-
edure. For instance, in patients with severely de-
ressed LV function, the number of pacing runs
hould be minimized to avoid hemodynamic com-
romise. The degree of baseline AR should be
valuated, because balloon dilation might worsen
he regurgitant lesion and cause hemodynamic
ompromise (21). In these cases, the team should be
repared to implant the valve expeditiously. Be-
ause catheters and wires are placed in the ventricle,
itral valve compromise might occur at any point
n the procedure and therefore the severity of mitral
egurgitation should be routinely assessed at base-
ine and throughout the procedure.
Routine and “Interventional” Imaging During THV
Implantation
Multimodality imaging goals. The goals of multimo-
dality imaging in the implantation phase include: 1)
ensuring the best prosthesis-patient match; 2) assessing
THV position and function after deployment; and
3) identifying immediate complications.
Figure 6. Determination of the Aortic Plane With Pre-Procedura
(A) Three-dimensional computed tomography reconstruction demo
caudal to left anterior oblique (LAO) cranial angles. (B and C) Aortic
valve plane with location of each leaﬂet, respectively. LCC  left co
See Online Video 1.Ensuring proper placement. ANGIOGRAPHY. Proper
alve placement depends on knowledge of the exact
ocation and orientation of the annular plane, which
hould be precisely defined either by angiography or
T scan before the procedure (22,23) and overlaid
n the screen with fluoroscopy (24) (Fig. 6). Rota-
ional angiography with pacing might also help to
efine this plane (25) (Online Fig. 3 and Video 1).
Figure 5. Localization of the LM Coronary Artery by Multi-Dete
Computed Tomography and 3D TEE
(A) Multi-detector computed tomography imaging used to acquire
of the left main (LM) coronary artery, with yellow arrow indicating
tance from the hinge point of the left coronary cusp to the LM, an
arrow indicating the length of the left coronary cusp. (B) Multiplan
struction of a 3-dimensional (3D) transesophageal echocardiograph
volume set in the transverse plane. The blue arrow shows the plan
LM coronary artery. (C) Multiplanar reconstruction of a 3D TEE volu
showing the plane of the LM ostium and coronary artery. This plan
to measure the length of the left coronary cusp (red arrow) and th
tance from the hinge point of that cusp to the LM coronary ostium
arrow) in systole. Ao  aorta; LV  left ventricle.
mputed Tomography Scan and Angiography
ating the aortic plane running from right anterior oblique (RAO)
t injection in LAO (B) and RAO (C) views demonstrates the aortic
ary cusp; NCC  noncoronary cusp; RCC right coronary cusp.ctor
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448In addition to fluoroscopic visualization of balloon
inflation (Online Fig. 4), injection of contrast at the
time of placement is helpful to make final adjust-
ments as necessary with slow balloon inflation and
for the final confirmation of the valve position. The
CoreValve (Medtronic) can be pulled up while
being deployed, if it is thought to be too deep in the
ventricle.
ECHOCARDIOGRAPHY. Transesophageal echocar-
iography provides continuous real time visualiza-
ion of the annulus, valve, and balloon, thereby
iding device placement and prediction and imme-
iate detection of AR. The desired “50-50” posi-
ioning of the SAPIEN (Edwards Lifesciences)
alve within the LVOT and aortic root depends on
roper identification of the hinge points of the
ative aortic valve leaflets and its relation to the extent
f the prosthesis above or below that point. This
andmark is not optimal, because the hinge points are
ot all at the same level within the oval-shaped
Transesophageal Echocardiography Biplane Imaging to Assess
imensions and Predict Aortic Regurgitation
imaging during balloon inﬂation. The green arrows identify the
e balloon at the level of the annulus. The blue arrow shows
c balloon dilation at the commissure between the left and non-
usps. The yellow arrows depict acoustic shadowing, which pre-
uate visualization of the peri-balloon region (see Online Video 2
ng image of using balloon aortic valvuloplasty for sizing). Biplane
mediately after transcatheter aortic valve replacement of the
(A) shows aortic regurgitation at the sites predicted during bal-
valvuloplasty (red arrows) (B). See Online Video 2.nnulus and at times can be difficult to visualize.ide-to-side exploration or biplane imaging might
inimize some of these limitations. Experience with
ntracardiac echocardiography is limited.
Differentiating the valve and balloon just proxi-
al to the valve with imaging can be difficult. To
vercome this, the operator can compare the length
f the stent segment by echocardiography with
nown stent length to confirm that the stent is
dentified accurately. Transesophageal echocardiog-
aphy can also be used to assess whether the
elivery system, including the valve, is coaxial to
he LVOT. The tips of the leaflets provide
nother echocardiography landmark necessary to
ake sure that the distal end of the SAPIEN
Edwards Lifesciences) stent covers the tip of
ative aortic valve, although the trajectory of the
elivery system in relation to the LVOT can also
ffect this interpretation.
Preventing, detecting, and managing AR. Transesopha-
geal echocardiography is particularly useful in pre-
dicting and managing acute AR (1,26,27). When it
is suspected that asymmetric calcification might affect
final THV shape, imaging during balloon aortic val-
vuloplasty can be used to localize regions of asymmet-
ric dilation and thus predict the localization of post-
TAVR AR (Fig. 7) (Online Video 2).
Although minor AR is common after TAVR,
moderate or severe AR is not common, occurring in
5% to 22% of cases (28,29). For both types of
THVs, the most important determinants of post-
TAVR AR are: undersizing of the prosthesis, the
extent of calcification of the valve, and the prosthe-
sis position in relation to the annulus (30). Studies
of the SAPIEN valve (Edwards Lifesciences) (14)
showed that the cover index (calculated as the
difference between the prosthesis diameter and
TEE annulus diameter, divided by the prosthesis
diameter) is also an important predictor of post-
TAVR AR. Moderate or greater AR was never
observed in patients with a cover index 8% (i.e.,
valve diameter 8% larger than the measured
annulus) (14). Valve anatomy, severity of calcifica-
tion, symmetry of valve opening, as well as the angle
of the LVOT/aorta have also been described by
others as potential determinants of post-TAVR AR
for the self-expanding valve (31).
To prevent paravalvular leak, the covered part of
the prosthesis must be well-apposed to the native
leaflets and interleaflet triangles. The ventricular
edge of the device must be just below the hinge
points of the aortic valve. If the balloon-expandable
valve is placed too deep within the LV, it canFigure 7.
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449commonly might leave native leaflets uncovered,
creating leaflet overhang—which alters the hemo-
dynamic status of THV valve closure and causes
significant central AR. If the valve is placed too
high within the aorta, it can potentially embolize
into the aorta, resulting in coronary artery obstruc-
tion or significant paravalvular regurgitation by
leaving significant portions of the valve apparatus
uncovered by the stent.
Placement of a self-expanding valve too deeply
into the ventricle can also cause considerable AR
through the uncovered part of the prosthesis (32).
Impingement and injury of the anterior leaflet of
the mitral valve is also a concern for “deeply” placed
valves. There is potential for paravalvular AR if 1 of
the commissures is not covered by the stent due to
high positioning. Alternatively, central AR can
result if the stent is “flared” too much on the aortic
side due to high positioning.
Immediately after valve deployment, TAVR
stent positioning, shape, leaflet motion, and AR can
rapidly be assessed with TEE imaging in biplane
mode (Fig. 7) or a single plane short-axis view (33).
For paravalvular regurgitation, the short-axis plane
of imaging should be just below the TAVR stent
and skirt and just within the LVOT; if the imaging
plane is above the stent, regurgitation might not be
visualized or color flow just above the annulus but
contained within the sinuses of Valsalva might be
mistaken for regurgitant jets into the LV. Confir-
mation of the severity of AR should always be
performed from multiple echocardiographic views.
The deep gastric view allows imaging of the LVOT
without acoustic shadowing (Fig. 8). Imaging the
entire annulus is mandatory and requires rotating
180° while centered on the valve. The severity of
AR typically lessens over the next 30 min after
implantation. Thus, small central or paravalvular
regurgitant jets are commonly seen and do not
require intervention. Patients with more than mild
paravalvular regurgitation, however, could be con-
sidered for a second balloon dilation (Online Fig. 5
and Online Videos 3 and 4). In many instances,
post-deployment balloon dilation results in an im-
mediate reduction in paravalvular regurgitation.
Other TAVR implantation complications. The diag-
ostic considerations in a severely hypotensive pa-
ient with post-deployment cardiovascular collapse
re not limited to AR, and real time multimodality
maging can detect and guide the management of
any of them. The differential diagnosis includes
oronary artery obstruction, pericardial tamponade,
evere mitral regurgitation, aortic dissection, LV dam- sge or perforation or rupture, and embolization of the
HV (34). As such, TEE or fluoroscopy can yield the
iagnosis within seconds by demonstrating a wall
otion abnormality, large pericardial effusion, color
ow signal of severe regurgitation, dissection of the
scending aorta or rupture of the annulus, and the
ocation of the THV, respectively (Online Videos 5, 6,
, and 8 for selected examples). Because of the
mplantation positioning of the ventricular portion of
he self-expanding valve, there has been a higher
eported incidence of heart block (32).
Long-Term Follow-Up
Multimodality imaging goals. The goals of post-
mplantation imaging include: 1) assessment of
alve hemodynamic status, including gradients and
ffective valve area; 2) quantification of valvular and
aravalvular regurgitation; 3) determination of the
ffect of implantation on the disease processes
elated to outflow obstruction (such as LV hyper-
rophy, chamber remodeling, diastolic and systolic
unction); 4) ongoing assessment of concomitant
athology; and 5) detection of long-term compli-
ations such as device migration, thrombus forma-
ion, ventricular perforation, mitral valve impinge-
ent, and endocarditis.
Evaluation of post-implantation THV function. Echo-
ardiography is the imaging modality of choice for
ong-term surveillance, because it provides substan-
ial benefits over other techniques, including wide-
Figure 8. Deep Gastric Transesophageal Echocardiography View
Paravalvular Aortic Regurgitation
Deep gastric transesophageal echocardiography views of post-trans
paravalvular aortic regurgitation (red arrows). Biplane imaging or a
image 360° of the annulus are required to fully assess the type and
regurgitation. See Online Videos 3 and 4 to see how TEE demonstr
paravalvular aortic regurgitation after a second balloon inﬂation.s to Visualize
catheter heart valve
full rotation to
severity of aortic
ates reduction ofpread availability, lack of need for ionizing radia-
i
d
a
D
w
t
d
s
g
w
h
d
3
s
g
a
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 4 , 2 0 1 2
A P R I L 2 0 1 2 : 4 4 1 – 5 5
Bloomfield et al.
Practical Guide to TAVR Imaging
450tion, and ability to image structures as well as
accurately measure hemodynamic status. Further-
more, both the SAPIEN (Edwards Lifesciences)
and CoreValve (Medtronic) systems have good
ultrasound imaging characteristics such that a de-
tailed assessment of position, hemodynamic status,
and of the types and degrees of AR with TTE is
possible without significant acoustic shadowing
(35,36) (Online Videos 9 and 10).
However, MDCT and CMR are playing larger
roles in the post-procedural evaluation of TAVR
patients, allowing the evaluation of structural integ-
rity, sphericity, position, aortic regurgitant volume,
and post-procedural complications (5) (Online Fig.
6). These modalities also afford excellent anatomic
detail, allowing for simultaneous assessment of the
prosthesis and its relationship to the native valve,
root, and ventricle as well as detecting pseudoaneu-
rysms of the root or apex and other rare complica-
tions (Fig. 9 and Online Fig. 7).
EVALUATION OF MYOCARDIAL FUNCTION AND HE-
MODYNAMIC STATUS. Left ventricular mass regres-
sion and improvement in ejection fraction (EF)
have been well-documented in patients after surgi-
cal aortic valve replacement (SAVR) for aortic
stenosis (37). Similarly, in patients undergoing
TAVR there are reductions in LV mass, modest
improvement in EF (38), and improved diastolic
function (39), and mitral regurgitation might im-
prove (40). A recent comparison of SAVR with
TAVR in patients with low EF showed a greater
increase in EF in the TAVR group (41). The LV
mass, size, and diastolic and systolic function
Figure 9. Pseudoaneurysm of the Aortic Root Visualized by
Multi-Detector Computed Tomography
Coronal multiplanar reconstruction of the aortic root in an
89-year-old female patient 3 days after transcatheter aortic valve
replacement. Difﬁculties with the rapid ventricular pacing were
encountered, resulting in a low deployment, root injury, and a
resultant pseudoaneurysm (arrow). See Online Videos 5, 6, 7,should thus be followed routinely after TAVR to
quantify the late effects of the hemodynamic
improvement. Echocardiography is the imaging
modality of choice in evaluating LV mass (42);
however, LV mass by CMR also offers a highly
accurate estimate (43).
GRADIENTS, VALVE AREA, AND DIMENSIONLESS
INDEX. Key metrics of prosthetic valve function
nclude mean and peak transvalvular pressure gra-
ients and the derived indexes of effective orifice
rea (EOA) and Doppler velocity index (DVI) (36).
etermination of valve gradients with continuous
ave Doppler is relatively straightforward, noting
hat suprasternal notch and right parasternal win-
ows and imaging and nonimaging Pedoff probes
hould be routinely used to ensure that maximal
radients are captured. Both the SAPIEN (Ed-
ards Lifesciences) and CoreValve (Medtronic)
ave excellent flow characteristics with mean gra-
ients of 10 to 15 mm Hg (Table 4) (44,45). The
-year results from a balloon-expandable valve (5)
uggest that a small increase in mean transvalvular
radient (3.8%/year) and a small reduction in valve
rea (0.06 cm2 /year) might occur over time.
Although calculations of EOA and DVI provide
flow-independent indexes of valve function, they
are more challenging to perform in THV than for
conventional surgical prostheses because the sup-
porting stent creates acceleration at both the level of
the stent and within the stent at the level of the
cusps (46) (Fig. 10). This unique flow characteristic
and the potential for variability in cross-sectional
area calculations make it imperative that the sub-
valvular velocities used in either the DVI or EOA
be routinely sampled proximal to the stent. Sam-
pling within the stent will result in an overestima-
tion of valve area or DVI. Additionally, inconsistent
sampling sites (within the stent at 1 time, below the
stent at another) will result in variable valve areas
that might be misinterpreted as changing valve
hemodynamic status.
The projection of the stent into the LVOT can also
lead to confusion as to the optimal site for measuring
LVOT diameter. Because there is reduced variability
and better correlation with transvalvular gradients
when EOA is calculated with diameters measured
immediately proximal to the stent (47), optimal as-
sessment of EOA and DVI for the SAPIEN valve
(Edwards Lifesciences) should employ velocities and
diameters obtained proximal to the valve stent. Theand 8.
flow characteristics of the CoreValve (Medtronic) and
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451the optimal site for measuring LVOT diameter for
this THV have not been reported.
Prosthesis-patient mismatch (P-PM) occurs
when the EOA of the implanted prosthesis is too
small in relation to body size, and severe P-PM is
defined by an EOA 0.65 cm2/m2. The P-PM
determines morbidity (48), LV mass regression
(49), and mortality (50) after SAVR. A consider-
able proportion (20% to 70%) of patients have
P-PM after open aortic valve replacement (30), but
this seems to be less of a problem after TAVR with
CoreValve (Medtronic) or SAPIEN (Edwards
Lifesciences) THVs (P-PM incidences 16% to 32%
and 6%, respectively) (30,51,52). Given that the
experience with TAVR is still growing, the long-
term imaging assessments after TAVR should in-
clude a thorough examination to document the
presence or absence of P-PM to understand the
Figure 10. Schematic and Examples of Spectral Doppler Flow A
(A) Schematic presentation of echocardiographic pulse-wave (PW) D
but pre-cusps, and continuous wave (CW) through the aortic valve.
ties used in either Doppler velocity index or effective oriﬁce area b
sample volume placed before stent. White arrows show the extent
the level of the prosthetic aortic cusps. (C) The PW Doppler pattern
PW Doppler pattern of a sample volume placed at the level of the
Table 4. Selected Published Gradients for the Edwards SAPIEN
Valve and Reference # Sample Size Mean Grad
SAPIEN Leon (1) 144 11.4
88 13.2
SAPIEN Smith (2) 287 9.9
246 10.2
SAPIEN Gurvitch (5) 70 10.0
37 12.1
CoreValve Buellesfeld (44) 126 8.5
126 9
CoreValve Gotzmann (45) 51 16
Mean gradient is mean  SD or interquartile range. *Core laboratory-adjudicat
EOA  effective oriﬁce area; NR  not reported.potential clinical significance of P-PM in this pop-
ulation.
PARAVALVULAR, TRANSVALVULAR, AND TOTAL AR.
Both transvalvular and paravalvular AR might be
seen after TAVR, with mild or less being the most
common severity found for either THV (26,28).
Differences between the balloon-expandable (SA-
PIEN [Edwards Lifesciences]) and self-expanding
valves (CoreValve [Medtronic]) have not been fully
characterized; however, in 1 registry (53) there was
an insignificant but higher odds ratio for significant
AR with the self-expanding valve. Follow-up echo-
cardiograms should identify the presence, location,
and severity of both types of regurgitation. The
optimal views for detection of regurgitant jets in-
clude the parasternal long-axis, short-axis, apical
long-axis, and 5-chamber views, although—due to
eration in a SAPIEN Transcatheter Heart Valve
ler patterns when the sample volume is placed pre-stent, in-stent
to ﬂow acceleration, it is imperative that the subvalvular veloci-
mpled proximal to the stent. (B) The PW Doppler pattern of a
he transcatheter heart valve in the aortic root. Red arrow shows
sample volume placed within the stent but before cusps. (D) The
s. See Online Videos 9 and 10.
Medtronic CoreValve Transcatheter Heart Valves
t (mm Hg) EOA (cm2) Follow-Up Period
7.0 1.5 0.4 30 days*
11.2 1.6 0.5 1 yr*
4.8 1.7 0.5; (n 279) 30 days*
4.3 1.6 0.5; (n 219) 1 yr*
2) 1.7 0.4 Hospital discharge
16.0) 1.4 0.3 3 yrs
4.0 NR 30 days
3.4 NR 2 yrs
0.5 1.96 0.3 1 yr
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452eccentric jets—off-axis views should also be used to
ensure accurate determination of the location and
severity of regurgitation. Color and spectral Dopp-
ler techniques are applied in a manner similar to
that of other prosthetic aortic valves (36), with
determination of flow convergence, measurement of
the vena contracta, and extent of regurgitation into
the LV and spectral Doppler parameters such as the
pressure half-time and holodiastolic flow reversal
into the descending aorta. Because both types of
regurgitation affect LV hemodynamic status, a
summary measurement of regurgitation, or “total
AR,” should routinely be calculated and measured
as outlined in the following text.
Significant transvalvular AR after TAVR is usu-
ally due to valvular damage during the implantation
procedure, too large a prosthesis for a small annulus
f Aortic Regurgitation Varies in Different Echocardiographic
regurgitation seems trivial in the short-axis view at the level of
Paravalvular aortic regurgitation grade is moderate in this off-axisd
of the same patient.resulting in valve deformation, or severe calcifica-
tion of the native valve leading to deformation of
the frame of the THV (54). Short-axis and off-axis
views can be especially helpful to characterize the
origin of the jet passing through the prosthetic
leaflets. With eccentric transvalvular AR jets, care
should be taken to measure the vena contracta in
the correct plane, because measurements of regur-
gitant jet width parallel to the LVOT measurement
risk overestimating the degree of regurgitation.
With the recent prosthetic valve guidelines, transvalvular
AR should be reported as: 1) mild; 2) moderate; or 3)
severe (55). Trivial or trace regurgitation might also be
noted.
Paravalvular AR (or paravalvular leak, perivalvu-
lar leak, or paraprosthetic regurgitation), in contrast
to transvalvular AR, is usually caused by incomplete
prosthesis apposition to the native annulus due to
remaining material of the native valve or ridges of
calcium, too small a prosthesis for a large annulus,
or too-low implantation of the valve leading to
paravalvular leakage through uncovered portions of
the prosthesis (54,56). Because paravalvular AR jets
travel along the natural curvature of the prosthesis-
annular interface, imaging in multiple planes is
necessary (Fig. 11) and might be difficult to differ-
entiate from transvalvular AR. The transthoracic
short-axis view is usually the best to view the true
orifice of paravalvular AR and helps to prevent the
overestimation of AR severity that can occur when
relying solely on apical views. With recently pro-
posed criteria for standard endpoint definitions for
TAVR clinical trials, the circumferential extent of
paravalvular AR can be graded with 10% being
associated with mild paravalvular AR, 10% to 20%
being associated with moderate, and 20% being
associated with severe AR (55) (Fig. 12). As with
ll AR parameters, the approximation of circum-
erential extent should be weighed with all other
vailable criteria for assessing the degree of regur-
itation.
The total amount of regurgitation is the most
mportant factor with regard to the hemodynamic
esponse to the increased volume load, which in
urn might affect chamber dilation, LV function,
nd development of pulmonary hypertension (57).
ombining information from color and spectral
oppler for both transvalvular and paravalvular AR
ith established grading criteria, the total AR
hould be part of the routine assessment after
AVR as an assessment of the total volume load. In
ost cases, this will be equal to the most severeFigure 11. Severity o
Windows
(A) Paravalvular aortic
the aortic annulus. (B)egree of AR of either transvalvular or paravalvular
D
C
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453AR. However, in some instances, the addition of
the 2 flows will push the grading to the next level of
severity (e.g., mild transvalvular AR plus mild-
moderate paravalvular AR are graded as moderate
total AR).
Quantitative assessments of regurgitant fraction
and regurgitant volume can also be helpful in
determining the severity of total AR (55). CMR
might be a useful supplement to echocardiogra-
phy and might be the modality of choice when
the degree is severe or when there is discordance
in grading from different echocardiographic win-
dows (58).
Multimodality imaging research opportunities in
TAVR. There is rich opportunity for research in
multimodality imaging related to TAVR, especially
because most work to date has been observational
and limited to a single THV device. As experience
develops, it follows that prospective studies should
be performed to compare different imaging strate-
gies and different THV devices. Along with this
work, the trial endpoints and methodologies pro-
posed by the Valve Academic Research Consortium
(55) and/or used by TAVR core laboratories need
to be validated to guide future clinical trials, obser-
vational studies, and state-of-the-art clinical practice.
Finally—although substantial redundancy in imag-
ing with multiple techniques to assess the same
structures or frequently repeated tests is war-
ranted initially—as experience grows, developing
a rational algorithm for imaging use both before
and after implant will become a priority.
There are also specific research opportunities at
each phase of TAVR patient care. Techniques for
pre-procedural assessment can be refined and em-
ployed in systematic comparisons of the accuracy of
different techniques in determining parameters,
such as annular dimensions and annulus to left main
coronary distance (e.g., a multi-center study that
randomizes patients to receive either annular sizing
with MDCT or echocardiography). Assessment of
the relative value of multimodality imaging findings
to select the optimal THV device as well as predic-
tors of subsequent implantation success and com-
plications are other important areas of investigation.
Much of the utility of imaging during implanta-
tion comes from offering real time guidance of the
procedure, including rapid detection of malposi-
tioning and complications. Because of the novelty
of TAVR, case reports and case series with imaging
are helpful to document the range of complications
and to educate less experienced implanting teams. EThe post-implantation THV assessments de-
tailed here reflect expert consensus, and their utility
should be validated by comparison with other tech-
niques and long-term outcomes. This is particularly
true for quantitative assessments of paravalvular,
transvalvular, and total AR—which might differ
slightly between devices—and the impact of total
AR on long-term cardiac structure, function, and
clinical outcomes. With regard to AR, more spe-
cific, reproducible, and quantitative criteria need to
be developed. Comparison of regurgitant volumes
obtained by 2D and 3D TTE and TEE, quantita-
tive Doppler, and CMR as well as consideration of
invasive and hemodynamic correlates will be infor-
mative and might refine the perceived significance
of this complication. The long-term clinical impact
of relief of pressure overload on regression of LV
hypertrophy, chamber remodeling, diastolic and
systolic function, mitral regurgitation, and other
compensatory or concomitant cardiac abnormalities
needs to be more fully characterized, compared
across THVs and with SAVR, and related to
functional status and outcome. In a similar way,
detection and quantification of P-PM and its fre-
quency and implications is an important and rich
area for future investigation.
Reprint requests and correspondence: Dr. Pamela S.
ouglas, 7022 North Pavilion, Duke University Medical
enter, PO Box 17969, Durham, North Carolina 27715.
Figure 12. Grading Criteria for Paravalvular AR
(A) Schematic and illustrated representation of the short-axis view
level of the aortic valve by echocardiography. (B) Echocardiographi
schematic illustrations of the short-axis view of the aortic valve. Par
aortic regurgitation (AR) can be graded according to the circumfere
extent of the regurgitant jet. Paravalvular AR can be graded as mild
ate, or severe on the basis of a circumferential extent of 10%, 10%
20%, or 20%, respectively. See Leon et al. (55). RV, right ventricle.
credit: CC Patrick J. Lynch and C. Carl Jaffe, Yale University, 2006.at the
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